Characterization of a key aminoglycoside phosphotransferase in gentamicin biosynthesis

Lei Shao1, Junsheng Chen, Chunxia Wang

  • 1State Key Lab of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, 1320 West Beijing Rd., Shanghai 200040, China.

Insights

Gentamicin

Area of Science:

  • Microbiology
  • Biochemistry
  • Molecular Biology

Background:

  • Gentamicin, an aminoglycoside antibiotic, is crucial for treating bacterial infections.
  • Its 3'-hydroxyl group absence confers resistance to bacterial modification enzymes.
  • C-3' dehydroxylation is a key step in gentamicin biosynthesis.

Purpose of the Study:

  • To investigate the role of phosphorylation in the C-3' dehydroxylation step of gentamicin biosynthesis.
  • To clone, overexpress, and characterize the gentamicin biosynthetic gene gntI.
  • To confirm the enzymatic activity of the GntI protein.

Main Methods:

  • Cloning and overexpression of the gentamicin biosynthetic gene gntI in Escherichia coli.
  • Purification of the aminoglycoside phosphotransferase encoded by gntI.
  • Determination of kinetic parameters for various aminoglycoside substrates.
  • Structural elucidation using NMR spectroscopy of phosphorylated kanamycin B.

Main Results:

  • The gntI gene was successfully cloned and the GntI protein was purified.
  • NMR data confirmed regiospecific phosphorylation at the 3'-hydroxyl group of kanamycin B.
  • Kinetic parameters for Kanamycin A, Kanamycin B, Neomycin B, and Amikacin were determined.
  • These findings provide partial confirmation that 3'-dehydroxylation is preceded by 3'-phosphorylation.

Conclusions:

  • The GntI enzyme, an aminoglycoside phosphotransferase, plays a role in gentamicin biosynthesis.
  • 3'-phosphorylation is a likely prerequisite for the 3'-dehydroxylation step in gentamicin production.
  • GntI may represent a novel group of aminoglycoside phosphotransferases involved in antibiotic biosynthesis.

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...